Reading Time: 4 minutesThis blog is part of the ‘Highlights from Glasgow’ collection of articles, where you can read about the content of some of the talks and
Tag: clinical trials
Reading Time: 8 minutesFollowing on from our previous catch-up blog on clinical management talks presented at the Symposium, here is a continuation that looks at talks focusing on
Reading Time: 4 minutesLooking for a treatment for MND is the ultimate goal of the whole MND community. Unfortunately, as MND is a very complicated disease, it is
Reading Time: 5 minutesIt’s been over a month since the announcement by the FDA of their decision to licence edaravone / Radicava for people with MND in the
Reading Time: 4 minutesEach year, the MND Association dedicates the month of June to raising MND awareness. This year, we focus on the eyes – in most people
Reading Time: 2 minutesOn Friday 5 May in America, the FDA, the organisation that approves drugs, announced that they’d granted a licence for the drug known as a
Reading Time: 2 minutesA few months ago we wrote an article about the ALS Clinical Trials Workshop which took place in Virginia, USA. Since then the Guidelines Working
Reading Time: 5 minutesClinical trials determine if potential treatments are safe and aim to prove beyond reasonable doubt whether a drug is beneficial. They are therefore the gold
Reading Time: 3 minutesBar a few bacteria usually found hitching a ride on our dental plaque and digestive system, every living cell in the human body needs oxygen.
Reading Time: 3 minutesThe MND Association’s Director of Research, Brian Dickie explains more about ‘GM6’, also known as ‘GM604’, a drug in development by an American pharmaceutical company